Krystal Biotech, Inc. (KRYS)
336.68
-3.35
(-0.99%)
USD |
NASDAQ |
Sep 15, 16:00
337.01
+0.33
(+0.10%)
After-Hours: 07:10
Krystal Biotech Price : 336.68 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 339.01 | 340.09 | 331.79 | 336.68 | 225818.0 |
| Sep 14, 2026 | 349.14 | 352.54 | 339.25 | 340.03 | 288543.0 |
| Sep 11, 2026 | 349.59 | 354.24 | 346.68 | 347.00 | 206324.0 |
| Sep 10, 2026 | 347.56 | 349.66 | 344.26 | 345.55 | 175788.0 |
| Sep 09, 2026 | 348.85 | 353.12 | 340.18 | 348.09 | 222382.0 |
| Sep 08, 2026 | 350.49 | 354.69 | 343.46 | 351.26 | 255881.0 |
| Sep 04, 2026 | 365.45 | 371.99 | 353.74 | 358.24 | 323022.0 |
| Sep 03, 2026 | 371.41 | 373.31 | 365.56 | 371.47 | 226492.0 |
| Sep 02, 2026 | 366.00 | 373.19 | 360.86 | 369.23 | 305202.0 |
| Sep 01, 2026 | 360.00 | 364.44 | 358.38 | 363.84 | 197426.0 |
| Aug 31, 2026 | 348.62 | 363.52 | 345.14 | 359.36 | 222775.0 |
| Aug 28, 2026 | 356.92 | 356.92 | 348.57 | 351.46 | 143509.0 |
| Aug 27, 2026 | 357.61 | 362.50 | 355.09 | 357.46 | 181432.0 |
| Aug 26, 2026 | 354.37 | 363.82 | 350.43 | 359.76 | 281025.0 |
| Aug 25, 2026 | 343.81 | 357.91 | 343.81 | 356.19 | 205048.0 |
| Aug 24, 2026 | 343.51 | 346.55 | 337.09 | 341.72 | 236705.0 |
| Aug 21, 2026 | 337.44 | 348.03 | 335.72 | 346.58 | 407806.0 |
| Aug 20, 2026 | 338.32 | 343.14 | 334.99 | 337.02 | 196704.0 |
| Aug 19, 2026 | 339.61 | 345.56 | 335.44 | 343.34 | 162843.0 |
| Aug 18, 2026 | 332.18 | 337.40 | 330.31 | 332.82 | 148470.0 |
| Aug 17, 2026 | 330.31 | 337.20 | 330.06 | 335.73 | 255136.0 |
| Aug 14, 2026 | 333.85 | 333.85 | 320.62 | 332.27 | 167864.0 |
| Aug 13, 2026 | 332.99 | 334.88 | 327.28 | 328.34 | 135629.0 |
| Aug 12, 2026 | 326.95 | 334.21 | 325.00 | 332.86 | 161952.0 |
| Aug 11, 2026 | 333.30 | 336.28 | 324.32 | 327.05 | 147902.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| TG Therapeutics, Inc. | 53.04 |
| Cytokinetics, Inc. | 69.31 |
| Alnylam Pharmaceuticals, Inc. | 238.27 |
| Exelixis, Inc. | 56.90 |
| Regeneron Pharmaceuticals, Inc. | 774.11 |
Price Related Metrics
| PE Ratio | 42.19 |
| PS Ratio | 23.17 |
| PEG Ratio | 0.677 |
| Price to Book Value | 7.332 |
| Price to Free Cash Flow | 39.59 |
| Earnings Yield | 2.37% |
| Market Cap | 9.964B |
| PEGY Ratio | 0.677 |
| Operating PE Ratio | 51.61 |
| Normalized PE Ratio | 42.19 |